FDA Authorizes Moderna And Pfizer-BioNTech Bivalent Covid-19 Vaccines For Use As A Booster Dose In Younger Age Groups

Rosenblatt Securities has reduced revenue estimates and slashed its price target on Microsoft Corporation (NASDAQ: MSFT) ahead of the software giant's Oct. 25 earnings report, citing increasing foreign exchange headwinds.